Terminal deoxynucleotidyl transferase (TDT) is a DNA polymerase enzyme which is normally only present in significant amounts in cortical thymocytes.' The discovery that the enzyme was present in lymphoblasts in acute lymphoblastic leukaemia (ALL) has led to the routine estimation of the enzyme as an accurate haemopoetic cell marker in ALL and lymphoblastic lymphomas.1-5 Normally biochemical estimations of the enzyme are carried out on cells obtained from blood and bone marrow in ALL and expressed quantitatively as units of enzyme activity per 108 white cells. Previous authors have not been impressed by the differences in absolute values of the enzyme in children and adults with ALL.1 6 In assessment of 26 cases, TDT estimations were performed on bone marrow or blood samples with greater than 90 % blasts and significant differences were obtained between the children and adult groups. This finding is of importance in the context of the known different prognosis of the adult and childhood disease.
Patients and methods
Twenty-six patients with ALL consisting of 13 adults and 13 children were studied. The diagnosis of ALL was made on examination of Romanowsky-stained slides of blood and bone marrow together with the FAB histological classification system.7 The biochemical estimation of TDT activity was used as a Accepted for publication 2 February 1981 confirmatory test of the diagnosis. Cells were examined for surface immunoglobulin by direct immunofluorescence (B cells) and for spontaneous rosette formation with sheep erythrocytes (T cells). The TDT estimation was performed on samples obtained from bone marrow (20) in the majority of cases or peripheral blood (6) containing greater than 90 % blasts as assessed by morphological means. Peripheral blood was assessed in those patients in whom sufficient marrow was not available. Nineteen cases were tested at the time of diagnosis; the remainder (7) were samples obtained at the initial relapse. Positive control samples were obtained from child thymus removed at routine paediatric cardiothoracic surgery. Blood and marrow samples available in routine haematological practice were also assayed. These included 10 patients with B cell chronic lymphatic leukaemia (peripheral blood), eight patients with myeloid leukaemia (relapse marrow), six patients with Hodgkin's disease (uninvolved marrow and blood), 10 patients with non-Hodgkin's lymphoma of the non-lymphoblastic type (marrow) and 34 control marrows from patients with non-malignant haematological disorders. Subsequently, the first remission bone marrows were available for assessment in 10 of the ALL patients.
METHOD FOR THE TDT ASSAY
Blood or marrow mononuclear cells were purified on a Ficoll Triosil gradient, counted and stored at -20°C within 6 h of collection at a concentration of 1-2 x 107 cells/50 ptl extraction buffer (0-25 M potassium phosphate pH 7 5 containing 1 mmol beta-mercaptoethanol). The enzyme assay was then carried out using the method of Hoffbrand et al. (1977) .6 Briefly, the cells were frozen and thawed three times and the extract spun at 100 000 g for 60 min; 10 ,ul of the supematant was then immediately assayed at 37°C for 1 h in a reaction mixture of 60 ,ul containing 0-025 units poly-d (adenine) as primer (P/L Biochemical Co, Milwaukee, USA), 83 ,umol/l 3H-deoxyguanasine triphosphate (Radiochemical Labs, Amersham) as substrate, 42 mmol/l tris-HCl (pH 7 5), 42 mmol/l potassium chloride, 4-2 mmol/l dithiothreitol (DTT, Sigma) and 80 ,umol/l manganous chloride. After incubation, 45 ul reaction mixture was transferred on to filter discs presoaked with 01 ml tetrasodiumpyrophosphate. The discs were dried and then washed in 10% and 5% trichloroacetic acid respectively, before drying and counting in 10 ml scintillation fluid in a betascintillation counter. Values were calculated in relation to the total protein content of the sample. The results were expressed as units per 108 cells, one being equivalent to the polymerisation by TDT of 1 nmol of nucleotide in one hour.6 The specificity of TDT activity was assessed by a series of estimations including the inhibition of the enzyme activity by the addition of 50 ,umol of ATP to the reaction mixture.
The ATP caused complete disappearance of all TDT activity excluding the possibility that high activities occurred as a result of non-specific DNA polymerase activity. Experiments assessing TDT activity after storage up to 48 h at 4°C or room temperature did not significantly alter the absolute TDT values.
Results
The values for TDT estimation are shown in Table  la and b and demonstrated in the Figure. The majority of adult patients were classified as FAB sub-group L2 and the five patients with the highest We would conclude from this preliminary series that a careful survey of quantitative TDT activity in ALL may reveal in adults a biological sub-population showing a higher concentration of TDT than childhood ALL. It would appear from previous work that such a high TDT sub-group would not correspond to common-ALL or "null" ALL2 8 found in adults, but may form a completely separate sub-group independent of immunological sub-types. We consider that the biochemical estimation of TDT maystill havean important part to play in the detailed classification of adult ALL and it would be inadvisable to rely totally on qualitative recognition of TDT by antibody techniques. 
